Search Results

Characterization of renal tubular apical efflux of zonampanel, an α-amino-3-hydroxy-5- methylisoxazole-4-propionate receptor antagonist, in humans

Authors: Minematsu, T.; Hashimoto, T.; Usui, T.; Kamimura, H.

Source: Xenobiotica, Volume 38, Number 9, September 2008 , pp. 1191-1202(12)

Publisher: Informa Healthcare

Spinal cord ionotropic glutamate receptors function in formalin-induced nociception in preweaning rats

Authors: King, Tamara; Barr, Gordon

Source: Psychopharmacology, Volume 192, Number 4, July 2007 , pp. 489-498(10)

Publisher: Springer

Pharmacological Intervention at Ionotropic Glutamate Receptor Complexes

Authors: Planells-Cases, Rosa; Lerma, Juan; Ferrer-Montiel, Antonio

Source: Current Pharmaceutical Design, Volume 12, Number 28, October 2006 , pp. 3583-3596(14)

Publisher: Bentham Science Publishers

Identification of metabolites of [ 14 C]zonampanel, an -amino-3-hydroxy-5-methylisoxazole-4-propionate receptor antagonist, following intravenous infusion in healthy volunteers

Authors: Minematsu, T.; Sohda, K.-Y.; Hashimoto, T.; Imai, H.; Usui, T.; Kamimura, H.

Source: Xenobiotica, Volume 35, Number 4, April 2005 , pp. 359-371(13)

Publisher: Informa Healthcare

Effect of AMPA receptor antagonist YM872 on cerebral hematoma size and neurological recovery in the intracerebral hemorrhage rat model

Authors: Terai K.; Suzuki M.; Sasamata M.; Yatsugi S.-i.; Yamaguchi T.; Miyata K.

Source: European Journal of Pharmacology, Volume 467, Number 1, 25 April 2003 , pp. 95-101(7)

Publisher: Elsevier

DOPA cyclohexyl ester potently inhibits aglycemia-induced release of glutamate in rat striatal slices

Authors: Hashimoto M.; Miyamae T.; Yamamoto I.; Goshima Y.

Source: Neuroscience Research, Volume 45, Number 3, March 2003 , pp. 335-344(10)

Publisher: Elsevier

Neuroprotective effects of YM872 coadministered with t-PA in a rat embolic stroke model

Authors: Suzuki M.; Sasamata M.; Miyata K.

Source: Brain Research, Volume 959, Number 1, 3 January 2003 , pp. 169-172(4)

Publisher: Elsevier

Glutamate AMPA Receptor Antagonist Treatment for Ischaemic Stroke

Authors: Akins P.T.; Atkinson R.P.

Source: Current Medical Research and Opinion, Volume 18, Supplement 2 to issue 2, 1 August 2002 , pp. 9-13(5)

Publisher: Informa Healthcare

Glutamate AMPA Receptor Antagonist Treatment for Ischaemic Stroke

Authors: Akins P.T.; Atkinson R.P.

Source: Current Medical Research and Opinion, Volume 18, Supplement 1 to issue 2, 1 March 2002 , pp. 9-13(5)

Publisher: Informa Healthcare

Neuroprotective effects of an AMPA receptor antagonist YM872 in a rat transient middle cerebral artery occlusion model

Authors: Kawasaki-Yatsugi S.; Ichiki C.; Yatsugi S.-i.; Takahashi M.; Shimizu-Sasamata M.; Yamaguchi T.; Minematsu K.

Source: Neuropharmacology, Volume 39, Number 2, February 2000 , pp. 211-217(7)

Publisher: Elsevier

Neuroprotective effect of the novel glutamate AMPA receptor antagonist YM872 assessed with in vivo MR imaging of rat MCA occlusion

Authors: Haberg A.; Takahashi M.; Yamaguchi T.; Hjelstuen M.; Haraldseth O.

Source: Brain Research, Volume 811, Number 1, 16 November 1998 , pp. 63-70(8)

Publisher: Elsevier

A novel AMPA receptor antagonist, YM872, reduces infarct size after middle cerebral artery occlusion in rats

Authors: Kawasaki-Yatsugi S.; Yatsugi S.-i.; Takahashi M.; Toya T.; Ichiki C.; Shimizu-Sasamata M.; Yamaguchi T.; Minematsu K.

Source: Brain Research, Volume 793, Number 1, 18 May 1998 , pp. 39-46(8)

Publisher: Elsevier